Treat to Target in Axial Spondyloarthritis Pros, Cons, and Future Directions

被引：7

作者：

Liew, Jean W. ^{[1
]}

Dubreuil, Maureen ^{[2
]}

机构：

[1] Univ Washington, Dept Med, Div Rheumatol, 1959 Northeast Pacific St,BB561, Seattle, WA 98195 USA

[2] Boston Univ, Sch Med, Sect Rheumatol, 650 Albany St,X201, Boston, MA 02119 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2020年 / 46卷 / 02期

基金：

美国国家卫生研究院;

关键词：

Treat to target; Disease activity; Axial spondyloarthritis; Ankylosing spondylitis; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SPINAL RADIOGRAPHIC PROGRESSION; ANKYLOSING-SPONDYLITIS; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; PHYSICAL FUNCTION; AMERICAN-COLLEGE; TIGHT CONTROL; MRI INFLAMMATION;

D O I：

10.1016/j.rdc.2020.01.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Treat to target describes a management paradigm that involves choosing a clinically relevant target, assessment with validated measures at a prespecified frequency, and a change in therapy if the target is not met. Although guidelines recommend treating to target in axial spondyloarthritis (axSpA), ideal methods to reach this target remain controversial. This review focuses on background for a treat-to-target strategy in axSpA. Potential targets of treatment, association of targets with outcomes, evidence of treatment impact on outcomes, and how treat to target has been incorporated into treatment guidelines are discussed. Treat-to-target trials and the research agenda for studies in axSpA are discussed.

引用

页码：343 / +

页数：15

共 50 条

[41] Navigating the complexities of difficult-to-treat axial spondyloarthritis
Ribeiro, Andre L.
Proft, Fabian
JOINT BONE SPINE, 2024, 91 (05)
[42] CHARACTERISTICS OF DIFFICULT TO TREAT AXIAL SPONDYLOARTHRITIS: A COMPARATIVE ANALYSIS
Delepine, T.
Cailliau, E.
Philippe, P.
Deprez, X.
Taisne, N.
Houvenagel, E.
Pascart, T.
Flipo, R. M.
Letarouilly, J. G.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 881 - 882
[43] APPLICATION OF THE DIFFICULT-TO-TREAT CONCEPT FOR AXIAL SPONDYLOARTHRITIS
Berbel Arcobe, L.
Roig Kim, M.
Brugarolas Martinez, E.
Domingo Carnice, A.
Vidal Montal, P.
Aguilar Coll, M.
Palacios Olid, J.
Maymo Paituvi, P.
Juanola-Roura, X.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1696 - 1696
[44] Defining the target: clinical aims in axial spondyloarthritis
Marzo-Ortega, Helena
Gaffney, Katie M.
Gaffney, Karl
RHEUMATOLOGY, 2018, 57 : 18 - 22
[45] TRABID: A NOVEL THERAPEUTIC TARGET FOR AXIAL SPONDYLOARTHRITIS
Srinath, A.
Mauro, D.
Korshko, M.
Aparnathi, M.
Foroozan, S.
Ciccia, F.
Haroon, N.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 18 - 19
[46] PROS AND CONS FOR THE IMPLEMENTATION OF TARGET COSTING METHOD IN ROMANIAN ECONOMIC ENTITIES
Briciu, Sorin
Capusneanu, Sorinel
PROCEEDINGS OF THE 8TH INTERNATIONAL CONFERENCE ACCOUNTING AND MANAGEMENT INFORMATION SYSTEMS (AMIS 2013), 2013, : 1032 - 1044
[47] SPONDYLOARTHRITIS Treat-to-target in spondyloarthritis-do we have a plan?
Maksymowych, Walter P.
NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (09) : 507 - 508
[48] Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives
Ali, I.
CURRENT CANCER DRUG TARGETS, 2011, 11 (02) : 131 - 134
[49] Pros, Cons, and Future Possibilities for Use of Computer Navigation in Hip Arthroscopy
Tannenbaum, Eric P.
Ross, James R.
Bedi, Asheesh
SPORTS MEDICINE AND ARTHROSCOPY REVIEW, 2014, 22 (04): : E33 - E41
[50] Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives
Bassetti, Matteo
Castaldo, Nadia
Carnelutti, Alessia
EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (14) : 1711 - 1718

← 1 2 3 4 5 →